EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 30th, 2010 • Proteonomix, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 30th, 2010 Company Industry JurisdictionThis EXCLUSIVE LICENSE AGREEMENT (the "Agreement") is entered into as of October 29, 2007 (the "Effective Date") by and between National Stem Cell Holding, Inc., a Delaware corporation, with its principal office at 187 Mill Lane, Mountainside, NJ 07052 ("NSC"); and Ian McNiece having an address 821 Majorca Ave, Coral Gables, FL 33134 ("Licensor").
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • January 28th, 2010 • Proteonomix, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 28th, 2010 Company Industry JurisdictionThis EXCLUSIVE LICENSE AGREEMENT (the "Agreement") is entered into as of October 29, 2007 (the "Effective Date") by and between National Stem Cell Holding, Inc., a Delaware corporation, with its principal office at 187 Mill Lane, Mountainside, NJ 07052 ("NSC"); and Ian McNiece having an address 821 Majorca Ave, Coral Gables, FL 33134 ("Licensor").
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • January 19th, 2010 • Proteonomix, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 19th, 2010 Company Industry JurisdictionThis EXCLUSIVE LICENSE AGREEMENT (the "Agreement") is entered into as of October 29, 2007 (the "Effective Date") by and between National Stem Cell Holding, Inc., a Delaware corporation, with its principal office at 187 Mill Lane, Mountainside, NJ 07052 ("NSC"); and Ian McNiece having an address 821 Majorca Ave, Coral Gables, FL 33134 ("Licensor").